Metformin, pioglitazone and gout risk

Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1127-1128. doi: 10.1002/pds.5516. Epub 2022 Aug 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / epidemiology
  • Drug Therapy, Combination
  • Gout* / drug therapy
  • Gout* / epidemiology
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Metformin* / adverse effects
  • Pioglitazone / adverse effects
  • Thiazolidinediones* / adverse effects

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Metformin
  • Pioglitazone